Novel Silicon-Containing Analogues of the Retinoid Agonist Bexarotene: Syntheses and Biological Effects on Human Pluripotent Stem Cells

Current and Emerging Treatment Strategies for Cutaneous T-cell Lymphoma

(2010) Frederick Lansigan et al.   DRUGS

Sila-Trifluperidol, a Silicon Analogue of the Dopamine (D2) Receptor Antagonist Trifluperidol: Synthesis and Pharmacological Characterization

(2010) Reinhold Tacke et al.   ORGANOMETALLICS

Large-scale synthesis of 1,1,3,3,6-pentamethyl-1,3-disilaindan-5-ol via a CoBr2/Zn-catalyzed [2+2+2] cycloaddition reaction

(2010) Ryo Mizojiri et al.   TETRAHEDRON

Bexarotene: a promising anticancer agent

(2009) Liyan Qu et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Synthesis and Pharmacological Characterization of Disila-AM80 (Disila-tamibarotene) and Disila-AM580, Silicon Analogues of the RARα-Selective Retinoid Agonists AM80 (Tamibarotene) and AM580

(2009) Reinhold Tacke et al.   ChemMedChem

Silicon Analogues of the RXR-Selective Retinoid Agonist SR11237 (BMS649): Chemistry and Biology

(2009) W. Peter Lippert et al.   ChemMedChem

In Vitro Metabolism of Haloperidol and Sila-Haloperidol: New Metabolic Pathways Resulting from Carbon/Silicon Exchange

(2009) T. Johansson et al.   DRUG METABOLISM AND DISPOSITION

Disila-Phantolide and Derivatives: Synthesis and Olfactory Characterization of Silicon-Containing Derivatives of the Musk Odorant Phantolide§

(2009) Stefan Metz et al.   ORGANOMETALLICS

Synthesis and evaluation of synthetic retinoid derivatives as inducers of stem cell differentiation

(2008) Victoria B. Christie et al.   ORGANIC & BIOMOLECULAR CHEMISTRY

Action of (R)-sila-venlafaxine and reboxetine to antagonize cisplatin-induced acute and delayed emesis in the ferret

(2008) Julie B. Warneck et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Sila-Haloperidol, a Silicon Analogue of the Dopamine (D2) Receptor Antagonist Haloperidol: Synthesis, Pharmacological Properties, and Metabolic Fate

(2007) Reinhold Tacke et al.   ChemMedChem